IACM

An organization focused on advancing cannabis medicine research is operated.

About IACM

IACM is a Healthcare company. An organization focused on advancing cannabis medicine research is operated. It operates on a Professional Services and Subscription Services model. IACM offers products and services including Cannabis-Talk Episodes, IACM Conference Recordings, and Monthly Meetings. Its focus areas include Medical Research and Cannabis Medicine.

Company details

The International Alliance for Cannabinoid Medicines (IACM) is dedicated to the advancement of research and education in the field of cannabis and cannabinoid medicines. Activities are centered around providing access to scientific content, organizing monthly expert meetings, and hosting conferences to shape the future of cannabis science. Support is offered to patients and professionals through exclusive content and networking opportunities. The organization operates within the healthcare sector, specifically targeting medical research related to cannabis therapeutics for various neuropsychiatric and chronic conditions.

Key Metrics
  • Latest Funding Round
    $337.5K (USD), Grant

    Mar 2007

  • Investors

Products & Services of IACM

IACM offers a comprehensive portfolio of products and services, including Cannabis-Talk Episodes, IACM Conference Recordings, and Monthly Meetings.

Cannabis-Talk Episodes
Educational Content

Episodes discussing cannabis and endocannabinoid system are provided.

IACM Conference Recordings
Educational Content

Recordings of cannabis science conferences are made available.

Monthly Meetings
Networking Events

Interactive sessions with experts are organized every month.

Funding Insights of IACM

  • Total Rounds 1
  • Last Round Grant β€” $337,500
  • First Round $337,500

    (Mar 2007)

  • Investors Count 1

All 1 funding rounds of IACM with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2007$337,500Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in IACM

IACM has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for IACM

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Web traffic of IACM

Websites that share an audience with IACM (cannabis-med.org).

Similar websites

Websites whose visitors overlap most with IACM. Affinity shows how closely the audiences match.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about IACM

The International Alliance for Cannabinoid Medicines (IACM) is dedicated to the advancement of research and education in the field of cannabis and cannabinoid medicines. Activities are centered around providing access to scientific content, organizing monthly expert meetings, and hosting conferences to shape the future of cannabis science. Support is offered to patients and professionals through exclusive content and networking opportunities. The organization operates within the healthcare sector, specifically targeting medical research related to cannabis therapeutics for various neuropsychiatric and chronic conditions.

IACM offers Cannabis-Talk Episodes, IACM Conference Recordings, and Monthly Meetings.

IACM has 1 investor. Key investors include HHS.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available